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Abstract
Background Bariatric surgery is accepted as an evidence-based treatment for morbid obesity. Many patients seek out body
contour surgery afterwards to correct acquired deformities. This study seeks to better define the impact of body contour surgery
on long-term weight loss.
Methods This study is a single-center retrospective review of 78 patients who underwent body contouring surgery post-Roux-enY gastric bypass compared with 221 matched control patients who underwent Roux-en-Y gastric bypass only. Data was collected
for patients at least 7 years post-Roux-en-Y gastric bypass.
Results Patients who underwent both bariatric surgery and body contour surgery maintained mean long-term weight loss of 58
kg. The matched control group mean weight loss over the same time interval was 42 kg. The difference was statistically and
clinically significant (p = 0.005). Change in body mass index, percent total weight loss, and percent excess body mass index loss
were all statistically significant between the 2 groups.
Conclusion Patients who underwent body contour surgery better maintained long-term weight reduction in comparison to those
who only had gastric bypass. Further understanding of the etiology of this association is important for patients contemplating
body contouring surgery.
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Introduction
Obesity remains a health epidemic affecting an estimated 30%
of the adult population in the USA [1, 2]. Bariatric surgery has
established itself as the standard treatment for this condition
by directly impacting weight loss as well as documented improvement in obesity-associated comorbidities. The most
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common bariatric procedures performed include laparoscopic
sleeve gastrectomy, Roux-en-Y gastric bypass (RYGB), and
gastric banding. In comparison, RYGB has been shown to
achieve better long-term outcomes [3–5]. Most weight loss
occurs in the first 2 years postoperatively. Unfortunately, it
is not uncommon for patients to regain up to 15% of the
previous weight lost [3, 6, 7].
Many factors impact weight gain after initial postsurgical
success. Educational efforts, close follow-up, programmatic
infrastructure, and support groups work with patients, family,
and friends around the time of surgery and long after for just
that reason [8]. Recruiting family and friend support and initiating behavioral changes are part of the preoperative optimization and informed consent in successful programs [9, 10].
Most US programs use presurgical screening and psychological testing to support the decision process to identify those
patients most likely to succeed [11]. Even with stringent
pretesting and close follow-up, long-term data shows a gradual regain of weight. In one study, the percent of excess
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weight loss decreased from 70% at 1 year to 49% by 14 years
[12]. Based on these statistics, more strategies are needed to
improve long-term weight loss.
For some patients, the success of bariatric surgery may be
tampered by new problems as a result of loose redundant,
irritated skin [13]. The positive feedback from successful
weight loss may be countered by episodes of intertrigo, rashes,
ill-fitting clothes, and general dissatisfaction with the new
body image. In one study, 75% of female and 68% of male
patients expressed interest in body contouring surgery (BCS)
after massive weight loss [14]. BCS encompasses a variety of
procedures to include abdominoplasty, panniculectomy,
brachioplasty, back lift, buttock lift, thighplasty, liposuction,
mastopexy, and breast reduction. All of which can be performed alone or in variable combinations and stages. BCS
has been shown to improve quality of life through improving
aesthetic outcomes and functionality as well. We previously
reviewed our 4-year results, which showed a trend towards
improved weight loss for bariatric surgery patients who
underwent BCS [15]. We now review our 7-year results.
Patient characteristics, including the amount of tissue surgically removed, for this population were also explored and
detailed. The aim of this study was to explore the long-term
outcomes of body contouring surgery in patients whom have
undergone bariatric surgery specifically looking at maintained
weight loss.

Materials and Methods
We conducted a retrospective analysis of our bariatric surgery
database from January 1, 2003, to December 31, 2018. During
this time period, 3668 patients underwent RYGB at our institution. Of these patients, 722 underwent post-gastric bypass
BCS. Seventy-eight patients met the inclusion threshold
criteria of 20 kg weight loss after RYGB, BCS, documentation of tissue removed, and follow-up of 7 years or more. In
the control group 34% and in the BCS 49% were still in the
system. Exclusion criteria included those who underwent gastric bypass at our institutions, but the follow-up was at an
institution we could get information from, those who
underwent non-RYGB weight loss surgery, and those without
clear documentation of the weight of tissue excised during
BCS. For the control group, we used patients from our own
institution who underwent RYGB, which had a documented
minimum 20 kg weight loss. For those patients who did not
follow-up long-term in the system, we obtained most recent
weight and body mass index (BMI) information from their
respective primary care provider with informed consent. For
the matched control group, we matched the study group patients for age (± 5 years), gender, and initial BMI (± 3 kg/m2).
We identified the amount of weight removed for each patient
at the time of BCS. For excised tissue, the specimen weight

was used. For suction-assisted lipectomy, 0.9 kg/ml was used
for density [16].
The primary outcomes measured were patient weight,
BMI, change in BMI, percent total weight loss, and percent
excess BMI loss at 7 years post-RYGB [17]. The Yale Food
Addiction Scale 2.0 was used as a validated measure to compare the patients [15, 18, 19]. Mean time from RYGB to BCS
for the study population was 2 ± 1.6 years. Demographic and
clinical data were collected for the study, and control populations were reviewed via the electronic health record. The study
was performed under institutional review board approval, and
all guidelines were followed.

Statistical Analysis
Statistical analysis was performed using SPSS version 16
(IBM, Armonk, NY). Patient demographics, such as age,
height, weight, BMI, and gender, were compared using
Student’s t-test and chi-square test. We also performed a univariate repeated measures analysis of variance that looked for
overall differences in BMI due to condition and time and then
explicitly tested the interaction between condition and time.

Results
For the study interval, 78 patients met inclusion criteria. The
matched control population had 221 patients for the same
interval. Comparative demographic information is shown in
Table 1. Populations were compared with respect to age, gender, initial BMI and weight, comorbidities, and standardized
screening tool. There was no statistical difference regarding
any of the characteristics for the 2 populations.
Table 1

Patient demographics

Age, years
Female gender %
Body mass index, kg/m2
Weight, kg
Diabetes diagnosis %
Hypertension diagnosis %
Food addiction diagnosisb
Length of follow-up, years

BCS (n = 78)a

Control (n = 221)

46 ± 9
78%
49 ± 3
136.3 ± 17
27%
46%
32%
8±4

48 ± 11
84%
48 ± 4
138.6 ± 18
31%
45%
34%
9±3

BCS, body contouring surgery
a

None of the values were statistically different between BCS group and
control group p > 0.05 (range 0.2–1.0)

b
Food addiction diagnosis by the Yale Food Addiction Scale version 2.0
[17]
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The patients who underwent BCS each underwent 1 or
more of 8 different procedures (Table 2). In most cases, patients underwent a combination of procedures (86%). None of
the patients sustained serious complications. Eleven patients
(15%) had minor complications, including cellulitis, seroma,
and minor wound dehiscence. Three patients required surgical
intervention related to the complication (4%). The most common procedure alone or in combination was abdominoplasty/
panniculectomy (68 patients) followed by liposuction (18 patients). The total weight removed was 4.2 ± 2.9 kg (range 2.2
to 9.8 kg) for all patients in the BCS group.
Primary outcomes were weight and BMI and relative
changes in these values for each patient individually from
baseline to 7 years post-RYGB (Table 3). For both groups,
weight and BMI were substantially lower than pre-RYGB
weights at all time points. By year 7, there was a statistically
significant difference in weight between the 2 groups, 19 kg (p
= 0.001). Relative to the pre-bariatric surgery baseline, the
BCS group lost an average 58.6 kg, and the matched control
group lost 41.7 kg. The statistical significance was maintained
even when we corrected for excised tissue weight in the BCS
group. The corrected BCS group weight loss at 7 years was
81.9 kg, and the difference from the control group was 15 kg
(p = 0.03). At year 7, the BMI difference between the cohorts
was also statistically significant (p = 0.02). Change in BMI,
Table 2 Specific operations for
body contouring surgery after
weight loss

percent total weight loss, and percent excess BMI loss were all
statistically significant in favor of the BCS compared to the
control group. Percent excess BMI loss was 27% higher for
the BCS group (p = 0.009).

Discussion
Patients who underwent BCS after bariatric surgery lost
achieve 13% higher total weight loss and 27% excess BMI
compared to those who did not undergo BCS over the same
interval. The statistical difference was maintained even when
we factored in the amount of tissue removed by the BCS. The
differences were less profound at the earlier measured time
points. For the BCS group, there was a downward trend in
weight for each of the time points. This group achieved over
50 kg loss from pre-bariatric surgery baseline. For the control
group, the weight trend was upward at the time points
reviewed. BMI followed a similar trend.
In our institution, approximately 19% of gastric bypass
patients elected to undergo BCS. This is higher than the national trend published in 2017 of 6% [20]. Individuals undergo bariatric surgery for many reasons including quality of life,
discomfort, self-esteem, and body image dissatisfaction [21,
22]. For those motivated strongly by body image, bariatric

Procedure

Frequency

Weight removal (kg)

Abdominoplasty
Abdominoplasty, back lift
Abdominoplasty, back lift, brachioplasty
Abdominoplasty, back lift, brachioplasty, breast reduction
Abdominoplasty, back lift, brachioplasty, liposuction, mastopexy
Abdominoplasty, back lift, brachioplasty, liposuction, thighplasty
Abdominoplasty, back lift, thighplasty
Abdominoplasty, brachioplasty

10
3
1
1
1
1
1
4

2.4 ± 2.0
4.0 ± 2.1
5.7
9.8
8.5
7.1
6.6
4.9 ±2.4

Abdominoplasty, brachioplasty, breast reduction
Abdominoplasty, brachioplasty, liposuction, thighplasty
Abdominoplasty, brachioplasty, mastopexy
Abdominoplasty, breast reduction
Abdominoplasty, liposuction
Abdominoplasty, mastopexy
Breast reduction, liposuction
Panniculectomy
Panniculectomy, back lift, brachioplasty
Panniculectomy, brachioplasty, liposuction, mastopexy
Panniculectomy, buttock lift, thighplasty
Panniculectomy, liposuction
Panniculectomy, mastopexy
Panniculectomy, thighplasty
Total

1
2
1
4
2
2
6
26
1
3
1
4
1
2
78

3.2
5.2 ± 4.6
4.6
3.7 ±2.2
3.5 ± 0.9
2.9 ± 1.5
6.5 ±3.7
4.8 ± 5.2
7.1
6.4 ± 2
6.9
4.6 ± 3.2
6.1
5.5 ± 2.7
4.2 ± 2.9
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Table 3 BMI and weight at
follow-up

Group

4 years

5 years

7 years

p value

BCS, body mass index, kg/m2
Control, body mass index, kg/m2
BCS, kg
Control, kg
BCS, kg; correctedb
BCS, change in BMIc
Control, change in BMI
BCS, percent total weight loss c
Control, percent total weight loss
BCS, percent excess BMI loss c
Control, percent excess BMI loss

33 ± 7
34 ± 6
85 ± 14
86 ± 21

33 ± 8
35 ± 6
81.3 ± 26
92.2 ± 16

30 ± 6
36 ± 7
77.7 ± 23
96.9 ± 19
81.9 ± 26
20 + 4
12 + 8
43%
30%
79%
52%

0.002a
0.001a
0.03a
0.02a
0.04a
0.01a

BCS, body contouring surgery; BMI, body mass index
a

Statistically significant at p < 0.05

b

Patient weight adjusted for tissue excised in conjunction with BCS. Only performed for year 7 because some
patients did not have surgery performed at the earlier time points.
c

The correct BCS weight at 7 years was use for this calculation.

surgery may not be the end of the struggle. Many of these
patients are left with excess hanging skin, displaced fatty tissue, and new sites of intertrigo. For this population, excess
skin may be a negative motivator for the maintenance of
weight loss. Patients who are medically, emotionally, and financially able to undergo BCS are able to eliminate the negative effects of this unintended consequence of bariatric surgery. Removing the excess tissue can serve as a positive motivator in this population [23]. This sets up a positive feedback
loop with other positive consequences. Alzahrani et al.
showed that there was a statistically significant and progressively incremental decrease in the rate of depression in those
patients sustaining > 30 kg weight loss [24]. There was also a
statistically significant increase in the patients’ social life, sex
life, daily activities, and job performance. These changes can
also feedback as positive reinforcement for further weight
loss.
Our results compare favorably to those reported in the literature. Others have confirmed the longitudinal benefits of
BCS in the massive weight loss population [13, 14, 25–28].
However, our work does vary from other published work. Our
7-year follow-up is on the longer end of most published literature. The majority of the large cohort longitudinal studies
were conducted in Europe. The European experience differs
in many ways from that in the USA. Our baseline pre-bariatric
surgery starting mean BMI and weight were 49 kg/m2 and 133
kg, respectively. This was about 10–15% higher than the
European studies reviewed. Although this may not be a statistical difference, it may represent a clinical difference with
respect to lifestyle choices, body self-image, and motivation.
Most reviewed studies did not include the amount of resected
tissue. In those in which the information was included, it was
often incomplete. Our mean excision of almost 5 kg was larger
than that in any of the studies we reviewed. This higher value

may be driven by the fact that the majority of US patients must
pay out of pocket for BCS (other than panniculectomy) and
theses patients are motivated to remove as much as possible.
We think it is important to include tissue excision information.
Without it, an adjusted weight cannot be calculated. For us,
this is an important comparison of the 2 populations. Our
corrected post-BCS weight maintained statistical difference
at 7 years, reinforcing the study conclusions. The implication
is that the excised tissue is not the sole reason for the clinical
differences identified. Without an explicit calculation of the
excised tissue, such a conclusion is not possible for other
studies. Not surprisingly, our post-procedure weights and
BMI were higher at all time points than most of the
European studies reviewed. Since we started out with a higher
baseline, a higher endpoint is understandable. Some studies
showed statistical difference between test and control populations at earlier time points than us. This may be related to the
wider range and later interval for BCS among our patients
compared to the other studies. In many European nations,
the BCS is a covered benefit and, therefore, more routinely
performed once patients meet the criteria. For many of our
patients, their surgery is self-financed. This probably contributes to the delay in treatment. Our bariatric population did not
differ much from the European studies with respect to age,
gender distribution, comorbidities, surgical complications,
and overall BMI trends.
Limitations of our study include its retrospective nature and
potential for selection bias. Cost of body contour surgery is a
definite confounding factor. Patients who underwent the surgery need access to funds to pay for the surgery and protected
time to recover from it. Interestingly, the 2 populations did not
vary much with respect to demographics reviewed in Table 1.
We believe this information may limit the impact, to some
degree, with respect to selection bias. Our choice of time
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points differs from the earlier time points in the literature,
making it difficult to compare among different published studies. There does not appear to be a time point standard in the
literature. For us, the BCS represents a new starting point for
weight loss. Because these operations begin 1 year after bariatric surgery and span up to 3 years, the first 4 years of
weights for the BCS group was difficult to interpret and have
a very large range. Trying to match for this in the control
group was difficult. We therefore elected to begin data collection at year 4 after bariatric surgery to get beyond the disparate
first and second surgery dates. This also required us to limit
our BCS group inclusion to the first 3 years after bariatric
surgery. Another limitation was the study size. Because of
our strict inclusion criteria, only 8% of the BCS at our institution were included. They may also have impacted the reported outcomes. Our overall population of patients undergoing BCS after bariatric surgery was 19%, higher than the USA
reported 6% but under the European 30–40% [19].
We believe BCS is an important factor for long-term
weight loss. Although we speculate this is true, we cannot
assign causation based on this work. It is also possible that
patients most motivated to maintain weight loss after bariatric
surgery are also self-selecting for BCS. We are working with
our bariatric colleagues to see if a different methodology, including different screening tools, may help answer this.
Our institution uses the Yale Food Addiction Scale as one
of many screening tools. We included it in the study design
because it is well-documented in the literature for bariatric
surgery screening. Future work is underway to investigate if
other scales may be more useful in identifying patients who
may or may not benefit from BCS after massive weight loss.

Informed Consent Informed consent was obtained from all individual
participants included in the study

Conclusion

11.

Patients undergoing BCS following RYGB have better longterm weight loss when compared to patients who only undergo RYGB. We posit that post-bariatric BCS is linked to improved success of bariatric surgery by impacting long-term
maintenance of weight loss. The exact mechanism is unclear,
and further investigation is warranted. The role of BCS in the
massive weight loss population appears to be more than just
aesthetic and may have quantifiable long-term health benefits.
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